TY - JOUR
T1 - Silent Retroperitoneal Fibrosis Associated With Methysergide Therapy
AU - Elkind, Arthur H.
AU - Friedman, Arnold P.
AU - Bachman, Arnold
AU - Siegelman, Stanley S.
AU - Sacks, Oliver W.
PY - 1968/10/28
Y1 - 1968/10/28
N2 - Intravenous urography was performed in 114 asymptomatic patients who had been treated with methysergide maleate for six months or longer. There were 13 abnormal urograms; 5 revealed congenital anomalies, and 5 showed medial deviation of the ureter but no other abnormalities. In three there was the characteristic picture of retroperitoneal fibrosis; two of these showed marked roentgenographic improvement after methysergide therapy was stopped, while in the third there was only partial improvement. Withdrawal of methysergide did not affect the medial deviation of the ureter. We recommend that a urogram be obtained at the start of methysergide therapy, and that urography be repeated at six-month intervals during therapy. Early recognition of silent ureteral obstruction may prevent renal damage, since the fibrosis usually regresses with drug withdrawal.
AB - Intravenous urography was performed in 114 asymptomatic patients who had been treated with methysergide maleate for six months or longer. There were 13 abnormal urograms; 5 revealed congenital anomalies, and 5 showed medial deviation of the ureter but no other abnormalities. In three there was the characteristic picture of retroperitoneal fibrosis; two of these showed marked roentgenographic improvement after methysergide therapy was stopped, while in the third there was only partial improvement. Withdrawal of methysergide did not affect the medial deviation of the ureter. We recommend that a urogram be obtained at the start of methysergide therapy, and that urography be repeated at six-month intervals during therapy. Early recognition of silent ureteral obstruction may prevent renal damage, since the fibrosis usually regresses with drug withdrawal.
UR - http://www.scopus.com/inward/record.url?scp=0014433361&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0014433361&partnerID=8YFLogxK
U2 - 10.1001/jama.1968.03150050029005
DO - 10.1001/jama.1968.03150050029005
M3 - Article
C2 - 5695652
AN - SCOPUS:0014433361
SN - 0098-7484
VL - 206
SP - 1041
EP - 1044
JO - JAMA: The Journal of the American Medical Association
JF - JAMA: The Journal of the American Medical Association
IS - 5
ER -